ISB News

Quantified Health: For Control Freaks or Is It the Future?

We've all heard the advice that we have to be our own advocates when it comes to healthcare. Larry Smarr (and other "self-quanters") has taken that to the Nth degree by collecting as much biological data about his body and using the information to improve his health. This feature article in MIT's Technology Review is a great read about Smarr's experience as The Patient of the Future.

Smarr will be a speaker at ISB's International Symposium on April 15-16. This year's topic is Systems Biology and the Microbiome. Visit the Symposium site for more information or to register.

Below is a recent video that features Smarr, Dr. Eric Topol, and others in the Quantified Self movement.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.